7.07
전일 마감가:
$6.93
열려 있는:
$6.89
하루 거래량:
97,025
Relative Volume:
0.54
시가총액:
$67.85M
수익:
$24.99M
순이익/손실:
$-115.01M
주가수익비율:
-0.4541
EPS:
-15.5702
순현금흐름:
$-100.36M
1주 성능:
+0.43%
1개월 성능:
-4.97%
6개월 성능:
-44.40%
1년 성능:
-43.17%
Adicet Bio Inc Stock (ACET) Company Profile
명칭
Adicet Bio Inc
전화
617-482-2333
주소
131 DARTMOUTH STREET, BOSTON
Compare ACET vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ACET
Adicet Bio Inc
|
7.07 | 66.50M | 24.99M | -115.01M | -100.36M | -15.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-30 | 재개 | Guggenheim | Buy |
| 2024-09-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-06-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-03-31 | 개시 | SMBC Nikko | Outperform |
| 2022-03-08 | 개시 | Truist | Buy |
| 2022-03-04 | 개시 | Jefferies | Buy |
| 2021-05-18 | 개시 | BTIG Research | Buy |
| 2021-04-23 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Canaccord Genuity | Buy |
| 2021-04-08 | 개시 | Guggenheim | Buy |
| 2020-11-04 | 개시 | B. Riley Securities | Buy |
| 2020-10-27 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-16 | 개시 | Wedbush | Outperform |
모두보기
Adicet Bio Inc 주식(ACET)의 최신 뉴스
Is Adicet Bio Inc currently under institutional pressurePortfolio Update Report & Daily Volume Surge Signals - baoquankhu1.vn
IPO Launch: Is Adicet Bio Inc on track to beat earningsWeekly Trend Report & Community Consensus Trade Signals - baoquankhu1.vn
Guggenheim Keeps Their Buy Rating on Adicet Bio (ACET) - The Globe and Mail
Adicet Bio, Inc. (ACET) Competitors - Meyka
Aug Patterns: Can Adicet Bio Inc continue delivering strong returns2026 Highlights & Target Return Focused Picks - baoquankhu1.vn
Clinical Trial Uncertainty Puts Adicet Bio’s Prula-cel Program and Financial Outlook at Risk - TipRanks
Guggenheim Issues Pessimistic Forecast for Adicet Bio (NASDAQ:ACET) Stock Price - MarketBeat
Guggenheim cuts Adicet Bio stock price target to $100 on valuation - Investing.com
ACET Stock Price, Quote & Chart | ADICET BIO INC (NASDAQ:ACET) - ChartMill
Adicet Bio Reports Strong 2025 Financial Results and Advances Key Autoimmune and Cancer Cell Therapy Programs - Minichart
Adicet Bio, Inc. 2025 Annual Report: Allogeneic Gamma Delta T Cell Therapy for Autoimmune Diseases and Cancer – Strategy, Risks, and Financial Overview - Minichart
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company - PharmiWeb.com
Adicet Bio (NASDAQ: ACET) files $250M shelf to issue stock, debt, warrants - Stock Titan
Adicet Bio (NASDAQ:ACET) Releases Earnings Results, Beats Expectations By $0.29 EPS - MarketBeat
Adicet Bio 10-K: $0 Revenue, $(16.95) EPS on $(116.8M) Net Loss - TradingView
ACET: 2025 net loss was $116.8M; prula-cel advanced in autoimmune trials, cash runway into 2027 - TradingView
Adicet Bio (NASDAQ: ACET) outlines 2025 loss and cash runway into 2027 - Stock Titan
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress - Bluefield Daily Telegraph
Adicet Bio (NASDAQ:ACET) Stock Passes Below 200 Day Moving AverageHere's What Happened - MarketBeat
VIX Spike: Is Adicet Bio Inc stock a good pick for beginners2025 Price Targets & Precise Buy Zone Identification - baoquankhu1.vn
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) PT at $69.00 - Defense World
Market Recap: Can Adicet Bio Inc continue delivering strong returnsTrend Reversal & Fast Moving Trade Plans - baoquankhu1.vn
Trading Recap: Is Adicet Bio Inc stock risky to hold now2025 Stock Rankings & Risk Controlled Stock Alerts - baoquankhu1.vn
ACET Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Adicet Bio, Inc. (NASDAQ:ACET) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Adicet Bio Inc expected to post a loss of $2.80 a shareEarnings Preview - TradingView
ACET Should I Buy - Intellectia AI
Forecast Cut: Does Rivian Automotive Inc stock benefit from AI growth2025 Winners & Losers & Consistent Income Trade Ideas - baoquankhu1.vn
Adicet Bio (ACET) Projected to Post Quarterly Earnings on Thursday - MarketBeat
CEO Moves: What drives NEXNs stock priceShare Buyback & Consistent Profit Alerts - baoquankhu1.vn
Portfolio Shifts: Is Adicet Bio Inc stock risky to hold now2025 Momentum Check & Safe Entry Trade Reports - baoquankhu1.vn
Entry Recap: Can Adicet Bio Inc continue delivering strong returnsIPO Watch & Pattern Based Trade Signal System - baoquankhu1.vn
Is Adicet Bio Inc. stock suitable for long term investingLayoff News & Smart Money Movement Alerts - mfd.ru
Aug Sectors: Is SRPRA part of any ETF2025 Volume Leaders & Safe Entry Point Alerts - baoquankhu1.vn
CEO Moves: Why is Marqeta Inc stock going downWeekly Trade Analysis & Real-Time Buy Zone Alerts - baoquankhu1.vn
Adicet Bio (ACET) holder Tang Capital reports 0.1% ownership stake - Stock Titan
Profit Recap: What analysts say about Adicet Bio Inc stock2025 AllTime Highs & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
EPS Watch: What analysts say about Adicet Bio Inc. stockTrade Risk Assessment & Weekly Watchlist for Hot Stocks - mfd.ru
Why retail investors favor Adicet Bio Inc. stockTrade Exit Summary & Daily Chart Pattern Signals - mfd.ru
Is now the right time to enter Adicet Bio Inc.July 2025 Volume & Capital Protection Trade Alerts - mfd.ru
How cyclical is Adicet Bio Inc. (1IJA) stock compared to rivalsPortfolio Risk Report & High Conviction Trade Alerts - mfd.ru
Can Adicet Bio Inc. continue delivering strong returns2025 Risk Factors & Stepwise Trade Signal Guides - mfd.ru
Adicet Bio, Inc. (NASDAQ:ACET) Receives $69.00 Consensus PT from Brokerages - Defense World
The Top 12 Companies Hiring in Biopharma Now - BioSpace
Adicet Bio, Inc. (NASDAQ:ACET) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Franklin Resources Inc. Acquires Significant Stake in Adicet Bio Inc. - GuruFocus
Earnings Miss: How does BOS Better Online Solutions Ltd score in quality rankings2025 Market Overview & AI Driven Price Predictions - baoquankhu1.vn
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - marketscreener.com
Biotech CEO’s Guggenheim 2026 summit talk to stream live - stocktitan.net
Aug Decliners: What is Lumen Technologies Incs book value per shareJuly 2025 Trade Ideas & Weekly High Return Forecasts - baoquankhu1.vn
Trend Review: Can Adicet Bio Inc be recession proofBond Market & Low Risk High Reward Ideas - baoquankhu1.vn
Adicet Bio Inc (ACET) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):